PT652287E - Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina - Google Patents
Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felinaInfo
- Publication number
- PT652287E PT652287E PT94306917T PT94306917T PT652287E PT 652287 E PT652287 E PT 652287E PT 94306917 T PT94306917 T PT 94306917T PT 94306917 T PT94306917 T PT 94306917T PT 652287 E PT652287 E PT 652287E
- Authority
- PT
- Portugal
- Prior art keywords
- poxvirus
- peritonite
- virus
- vectors
- feline
- Prior art date
Links
- 241000282324 Felis Species 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 241000711475 Feline infectious peritonitis virus Species 0.000 abstract 3
- 241000700638 Raccoonpox virus Species 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/819—Viral vaccine for feline species, e.g. cats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12551693A | 1993-09-22 | 1993-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT652287E true PT652287E (pt) | 2003-06-30 |
Family
ID=22420074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94306917T PT652287E (pt) | 1993-09-22 | 1994-09-21 | Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5770211A (pt) |
| EP (1) | EP0652287B1 (pt) |
| JP (2) | JPH07184662A (pt) |
| AT (1) | ATE233821T1 (pt) |
| AU (1) | AU680531B2 (pt) |
| CA (1) | CA2132374C (pt) |
| DE (1) | DE69432207T2 (pt) |
| DK (1) | DK0652287T3 (pt) |
| ES (1) | ES2188605T3 (pt) |
| NZ (1) | NZ264518A (pt) |
| PT (1) | PT652287E (pt) |
| SG (1) | SG55095A1 (pt) |
| TW (1) | TW377373B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020123476A1 (en) * | 1991-03-19 | 2002-09-05 | Emanuele R. Martin | Therapeutic delivery compositions and methods of use thereof |
| US7202225B1 (en) * | 1993-10-15 | 2007-04-10 | Emanuele R Martin | Therapeutic delivery compositions and methods of use thereof |
| US7087234B1 (en) | 1991-07-09 | 2006-08-08 | Cornell Research Foundation, Inc. | Recombinant multivalent viral vaccine |
| US6241989B1 (en) * | 1991-07-09 | 2001-06-05 | Cornell Research Foundation, Inc. | Recombinant multivalent viral vaccine |
| US5820869A (en) * | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| US5858373A (en) * | 1995-12-01 | 1999-01-12 | Virogenetics Corporation | Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| FR2751223B1 (fr) | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
| AU5597998A (en) * | 1996-12-04 | 1998-06-29 | Heska Corporation | Recombinant plague vaccine |
| WO1998049195A1 (en) * | 1997-04-29 | 1998-11-05 | Universiteit Utrecht | Corona virus-like particles as tools for vaccination and therapy |
| US6106841A (en) * | 1998-02-04 | 2000-08-22 | Heska Corporation | Delivery method for recombinant raccoon poxvirus |
| US20050161884A1 (en) * | 1998-02-17 | 2005-07-28 | Au-Yeung Chi F. | Method of and apparatus for playing a card game |
| UA73718C2 (en) * | 1998-05-01 | 2005-09-15 | Schering Plough Ltd | Therapeutic vector expressing foreign dna, coding cat's cd80, cat's cd86, cat's cd28 or cat's ctla-4 and use thereof |
| US7279168B2 (en) | 1998-05-01 | 2007-10-09 | Texas A & M University System | Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof |
| PT1370668E (pt) | 2001-03-08 | 2006-06-30 | Akzo Nobel Nv | Vacinas de vector baseadas em leporipox |
| US7255986B2 (en) * | 2002-01-31 | 2007-08-14 | The Board Of Trustees Operating Michigan State University | Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets |
| JP4242607B2 (ja) * | 2002-07-04 | 2009-03-25 | 学校法人北里研究所 | ネコ伝染性腹膜炎ワクチン |
| AU2008260593A1 (en) * | 2007-05-30 | 2008-12-11 | Wyeth | Raccoon poxvirus expressing genes of feline antigens |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE1070T1 (de) * | 1978-11-30 | 1982-06-15 | The Wellcome Foundation Limited | Abgeschwaechter stamm des bei feliden infektioese peritonitis verursachenden virus, verfahren zu seiner herstellung und ihn enthaltender impfstoff. |
| US4293653A (en) * | 1979-04-12 | 1981-10-06 | Horzinek Marian C | Method for propagating feline infectious peritonitis virus |
| US4303644A (en) * | 1979-10-16 | 1981-12-01 | Norden Laboratories, Inc. | Feline infectious peritonitis virus vaccines |
| EP0264979A1 (en) * | 1986-09-05 | 1988-04-27 | Duphar International Research B.V | New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines |
| US5266313A (en) * | 1987-02-03 | 1993-11-30 | The United States Of America As Represented By The Department Of Health And Human Services | Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
| IL87911A0 (en) * | 1987-10-01 | 1989-03-31 | Norden Lab Inc | Vaccine for protection of cats against feline infectious peritonitis |
| CA2005291C (en) * | 1988-12-30 | 1999-01-26 | Beverly Dale | Feline infectious peritonitis virus diagnostic tools |
| CA2011025A1 (en) * | 1989-03-01 | 1990-09-01 | Terry R. Beardsley | Feline infectious peritonitis vaccine |
| CA2020740A1 (en) * | 1989-07-12 | 1991-01-13 | Harry Vennema | Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines |
| US5242686A (en) * | 1990-11-07 | 1993-09-07 | American Home Products Corporation | Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same |
| NZ240558A (en) * | 1990-11-14 | 1994-11-25 | Smithkline Beecham Corp | Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease |
| AU2347692A (en) * | 1991-07-09 | 1993-02-11 | Cornell Research Foundation Inc. | Recombinant viral vaccine |
-
1994
- 1994-08-30 TW TW083107942A patent/TW377373B/zh not_active IP Right Cessation
- 1994-09-19 JP JP6223293A patent/JPH07184662A/ja not_active Ceased
- 1994-09-19 CA CA002132374A patent/CA2132374C/en not_active Expired - Fee Related
- 1994-09-21 PT PT94306917T patent/PT652287E/pt unknown
- 1994-09-21 AT AT94306917T patent/ATE233821T1/de not_active IP Right Cessation
- 1994-09-21 AU AU74116/94A patent/AU680531B2/en not_active Ceased
- 1994-09-21 EP EP94306917A patent/EP0652287B1/en not_active Expired - Lifetime
- 1994-09-21 SG SG1996005965A patent/SG55095A1/en unknown
- 1994-09-21 DE DE69432207T patent/DE69432207T2/de not_active Expired - Fee Related
- 1994-09-21 ES ES94306917T patent/ES2188605T3/es not_active Expired - Lifetime
- 1994-09-21 DK DK94306917T patent/DK0652287T3/da active
- 1994-09-22 NZ NZ264518A patent/NZ264518A/en not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/480,210 patent/US5770211A/en not_active Expired - Lifetime
- 1995-06-07 US US08/480,882 patent/US5656275A/en not_active Expired - Lifetime
-
2005
- 2005-08-10 JP JP2005232394A patent/JP2005336206A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE233821T1 (de) | 2003-03-15 |
| AU680531B2 (en) | 1997-07-31 |
| EP0652287B1 (en) | 2003-03-05 |
| US5770211A (en) | 1998-06-23 |
| TW377373B (en) | 1999-12-21 |
| DE69432207D1 (de) | 2003-04-10 |
| CA2132374C (en) | 2005-05-17 |
| JP2005336206A (ja) | 2005-12-08 |
| ES2188605T3 (es) | 2003-07-01 |
| DK0652287T3 (da) | 2003-04-07 |
| JPH07184662A (ja) | 1995-07-25 |
| EP0652287A3 (en) | 1997-06-11 |
| SG55095A1 (en) | 1998-12-21 |
| DE69432207T2 (de) | 2003-11-13 |
| AU7411694A (en) | 1995-04-06 |
| US5656275A (en) | 1997-08-12 |
| CA2132374A1 (en) | 1995-03-23 |
| EP0652287A2 (en) | 1995-05-10 |
| NZ264518A (en) | 1996-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT652287E (pt) | Vectores de poxvirus e sua utilizacao contra doenca pelo virus da peritonite infecciosa felina | |
| ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
| CO4750842A1 (es) | Pox virus recombinantes de mapache y vacuna eficaz contra la infeccion del virus de inmunodeficiencia felina . | |
| ATE334216T1 (de) | Impstoff gegen felines immunodefizienz-virus | |
| BR9608615A (pt) | Vacinas de vírus sincicial respiratório de ácido nucléico | |
| GR3030811T3 (en) | Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof | |
| CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
| ATE241014T2 (de) | Hiv-2 varianten | |
| MX9202512A (es) | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. | |
| DK0661999T3 (da) | Vacciner mod felint immundefekt virus (FIV) | |
| HUP0000356A2 (hu) | Hibás vírusgenomokon alapuló rekombináns vektorok és alkalmazásuk vakcinák kialakítására | |
| NZ242471A (en) | Canine corona virus spike protein encoding sequences and vaccines containing the recombinantly produced protein | |
| ATE543513T1 (de) | Anti-coronavirus impfstoff | |
| WO1995005460A3 (en) | Feline immunodeficiency virus isolate ncsu 1 | |
| BR0010222A (pt) | Vetores de expressão viral | |
| DK0623172T3 (da) | Rekombinant Mareks sygdomsvirus-poxvirusvaccine | |
| KR960705047A (ko) | 신규 단백질/폴리펩티드와 동시트랜스펙션 플라스미드 및 생조환형 담체 | |
| WO2001049712A3 (en) | Vaccine against isav (infectious salmon anaemia virus) | |
| ES2105984A1 (es) | Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. | |
| NO942075L (no) | Rekombinante virus omfattende kunstig proteolytisk spaltingssete | |
| NO902491D0 (no) | Proteiner, vaksiner og nukleinsyrer. | |
| TH31605A (th) | รีคอมบิแนนท์แรคคูนพอกซ์ไวรัสและการใช้มันต่อการติดเชื้อไวรัสก่อโรคภูมิพร่องในแมว | |
| TH44441A (th) | วัคซีนไวรัสไข้เหลืองชนิดรีคอมบิแนนท์ที่ได้กลับคืนจาก cDNA ที่ติดเชื้อ |